Skip to content

Study on the correlation between gene mutation and TCM syndrome types in metastatic colorectal cancer

Study on the correlation between gene mutation and TCM syndrome types in metastatic colorectal cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039649
Enrollment
Unknown
Registered
2020-11-04
Start date
2020-11-03
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic colorectal cancer

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Those patients with definite pathological diagnosis of colorectal cancer; 2. Patients with complete TNM staging information; 3. Patients with definite location and time of metastasis; 4. Aged >= 18 years old and <= 80 years old, male and female are not limited; 5. Patients with definite first treatment time of traditional Chinese medicine; 6. Patients who can receive long-term follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with colorectal cancer pathologically diagnosed as adenosquamous carcinoma, squamous cell carcinoma, carcinoid, small cell carcinoma, malignant lymphoma, etc; 2. Patients with double cancer, multiple or metastatic colorectal cancer; 3. Patients with severe acute and chronic diseases that may affect the treatment and prognosis, such as myocardial infarction, stroke, severe renal insufficiency and mental illness.

Design outcomes

Primary

MeasureTime frame
gene mutations;

Countries

China

Contacts

Public ContactZhu Yingjie

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

yjzzz1998@126.com+86 18917763388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026